This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Calgary directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $688,500
Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: A Multinational Cluster Randomized Crossover Trial
CIHR · 2021 · Principal investigator
Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: A Multinational Cluster Randomized Crossover Trial
Principal investigators: Freedman, Stephen B; Goldstein, Stuart L; Grisaru, Silviu; Pavia, Andrew T; Schnadower, David; Tarr, Phil
Keywords: Acute Kidney Injury; Cluster Randomized Crossover Clinical Trial; Hemolytic Uremic Syndrome; Intravascular Volume Expansion; Pediatric; Pragmatic Trials; Renal Replacement Therapy; Shiga Toxin-Producing Escherichia Coli
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.